Daré Bioscience
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Daré Bioscience generated cash of -$38,856,654, which is less than the previous year. Cash used in financing activities reached the amount of $15,637,120 last year. Net change in cash is therefore -$23,858,549.
Cash Flow
| 2014 | -19.06M | -185K | 64.93M |
|---|---|---|---|
| 2015 | -31.91M | -484K | 57.13M |
| 2016 | -33.53M | -418K | -7.00M |
| 2017 | -2.54M | 9.91M | 155K |
| 2018 | -10.26M | -518.83K | 10.11M |
| 2019 | -13.31M | 6.14M | 5.15M |
| 2020 | -25.23M | -17.62K | 25.13M |
| 2021 | -28.76M | -14.52K | 75.84M |
| 2022 | -18.08M | -63.06K | 1.34M |
| 2023 | -38.85M | -629.43K | 15.63M |
DARE Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 34.66M | 51.67M | 4.66M | 4.78M | 6.80M | 7.55M | 44.61K | 75.90M | 51.17M | 5.48M |
Operating activities | ||||||||||
Net income | -30.16M | -30.94M | -38.69M | -27.40M | -14.26M | -16.73M | -11.50M | -39.30M | -39.59M | -23.34M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 38.36K | 24.20K | 26.41K | 43.22K | 11.13K | 2.44K | 0 | 261K | 192K | 126K |
Stock-based compensation expense | 2.53M | 2.15M | 1.59M | 742.03K | 462.23K | 0 | 15.83K | 2.75M | 2.37M | 885K |
| Deferred income tax benefit | 2.53M | 2.15M | 1.59M | 742.03K | 462.23K | 0 | 15.83K | 2.75M | 2.37M | 885K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 753.94K | -557.84K | -685.14K | 95.04K | -201.42K | 253.16K | 662.05K | -446K | 342K | -713K |
Inventories | 0 | 557.84K | 685.14K | -95.04K | 201.42K | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 1.35M | -75.13K | 1.08M | -61.85K | 608.65K | 151.48K | 753.09K | -603K | 795K | 341K |
Cash generated by operating activities | -38.85M | -18.08M | -28.76M | -25.23M | -13.31M | -10.26M | -2.54M | -33.53M | -31.91M | -19.06M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -230K | 0 |
Investments In Property Plant And Equipment | -629.43K | -63.06K | -14.52K | -17.62K | 0 | -11.83K | 0 | -535K | -277K | -225K |
Acquisitions Net | 0 | 925M | 925M | 0 | 6.14M | -507K | 9.91M | 0 | 23K | 0 |
Cash generated by investing activities | -629.43K | -63.06K | -14.52K | -17.62K | 6.14M | -518.83K | 9.91M | -418K | -484K | -185K |
Financing activities | ||||||||||
Common Stock Issued | 9.34M | 1.21M | 75.31M | 22.97M | 5.15M | 10.11M | 0 | 918K | 39.81M | 60.00M |
Payments for dividends | 0 | 0 | 0 | 0 | -789.59M | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | -367.28K | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 267.18K | 0 | 0 | -367.28K | 0 | 0 | 155K | -7.92M | 17.67M | -3.34M |
Cash used in financing activities | 15.63M | 1.34M | 75.84M | 25.13M | 5.15M | 10.11M | 155K | -7.00M | 57.13M | 64.93M |
Net Change In Cash | -23.85M | -17.00M | 47.00M | -110.64K | -2.02M | -753.95K | 7.51M | -40.95M | 24.73M | 45.68M |
Cash at end of period | 10.81M | 34.66M | 51.67M | 4.66M | 4.78M | 6.80M | 7.55M | 34.95M | 75.90M | 51.17M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |